In an effort to delay the aging process, scientists at the University of Washington and Texas A&M University are experimenting on dogs with a drug that could change everything. The multi-year Dog Aging Project will test rapamycin, a pharmaceutical drug normally used in cancer and organ transplant treatment that’s shown to slow the aging process in mice in previous research. Veuer’s Maria Mercedes Galuppo has the story.
